These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 22983959)
1. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Thomsen M; Dahl M; Lange P; Vestbo J; Nordestgaard BG Am J Respir Crit Care Med; 2012 Nov; 186(10):982-8. PubMed ID: 22983959 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083 [TBL] [Abstract][Full Text] [Related]
3. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients. Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730 [TBL] [Abstract][Full Text] [Related]
4. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations]. Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550 [TBL] [Abstract][Full Text] [Related]
5. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413 [TBL] [Abstract][Full Text] [Related]
6. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Sode BF; Dahl M; Nordestgaard BG Eur Heart J; 2011 Oct; 32(19):2365-75. PubMed ID: 21875856 [TBL] [Abstract][Full Text] [Related]
7. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197 [TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical markers of obstructive lung disease in the general population. Dahl M Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein in patients with COPD, control smokers and non-smokers. Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583 [TBL] [Abstract][Full Text] [Related]
10. [Incidence of comorbidities in hospitalized chronic obstructive pulmonary disease patients and correlated risk factors]. Chang C; Yao WZ; Fang TS Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(14):943-7. PubMed ID: 22781564 [TBL] [Abstract][Full Text] [Related]
11. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection. Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388 [TBL] [Abstract][Full Text] [Related]
12. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease]. Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002 [TBL] [Abstract][Full Text] [Related]
15. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H; Luo H; Chen P; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [TBL] [Abstract][Full Text] [Related]
16. [The relationship between inflammatory mediators and pulmonary hypertension in patients with chronic obstructive pulmonary disease]. Jiang YW; Pang L; Fang QH; Ma YM Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):904-8. PubMed ID: 22333502 [TBL] [Abstract][Full Text] [Related]
17. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment. Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744 [TBL] [Abstract][Full Text] [Related]
18. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. MacNee W Ann Med; 2013 May; 45(3):291-300. PubMed ID: 23110517 [TBL] [Abstract][Full Text] [Related]
19. C-reactive protein levels in stable COPD patients: a case-control study. Silva DR; Gazzana MB; Knorst MM Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470 [TBL] [Abstract][Full Text] [Related]
20. The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients. van Dijk WD; Akkermans R; Heijdra Y; Weel Cv; Schermer TR; Scheepers PT; Lenders JW Biomark Med; 2013 Apr; 7(2):211-9. PubMed ID: 23547816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]